FDA Recalls 500 Medicines. The FDA announced on Wednesday that it will remove unapproved prescription cough, cold and allergy medications from the market as part of its ongoing initiative to stop the sale of drugs that aren’t up to current standards.
Over 500 prescription medications are involved in the atest round up, including Pseudo Cough Syrup, ColdMist Extended Relief tablets and Pediahist, a cold formula labeled for babies as young as one month old. You can find the complete list of products on the FDA’s website.
Many doctors and health care providers unaware of the status of certain drugs have continued to prescribe them because the labels do not disclose that they lack FDA approval, according to the agency.
“Removing these unapproved products from the market will reduce potential risks to consumers,” Deborah Autor, director of the Office of Compliance at the FDA’s Center for Drug Evaluation and Research said in a written statement.
Such a widespread recall begs the question: How exactly did these products end up on the market in the first place?
As MainStreet has previously reported, these drugs were essentially grandfathered onto store shelves. While the FDA now requires that companies submit all new prescription drugs for review before they are put on the market, they haven’t always.